Tweets
Spondyloenchondrodysplasia - Very rare genetic skeletal dysplasia w/ short stature, platyspondyly, short broad ilia and enchondromas in long bones or pelvis. Varied phenotype w/ CNS (spasticity, retardation) & autoimmune (ITP, SLE, AIHA, thyroiditis) https://t.co/4DHqohjb2Z https://t.co/Bafh1v0MOA
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
NEJM: Dysphagia Due to Diffuse Idiopathic Skeletal Hyperostosis - 70yoM with 6-month history of dysphagia. Compression of the hypopharyx by large cervical osteophytes was seen in a videofluoroscopic swallowing study https://t.co/lp93QwiZlz https://t.co/jI070aQB2F
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
Dr. Kent Kwoh and Researchers at the University of Arizona Arthritis Center have been awarded a $3.4 million grant from the National Institutes of Health to undertake a study that seeks to identify determinants of rapid knee deterioration in OA https://t.co/K9wxRzmVnw https://t.co/nM7ByxKikB
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
Anakinra in Pericarditis: A Systematic Review (comprehensive, full read) -Options include steroids, colchicine, NSAIDs, pleuropericardial window, IL-1 inhibitors. ANAKINRA - 11 studies, 259 pts, all showing significant rapid resolution. https://t.co/mEkaa7Yjt1 https://t.co/BaMYHiG5Pb
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
Highlights from the @ACRheum Kawasaki Disease Guidelines
🥇IVIG is mainstay therapy (2 g/kg)
👶🏼 Use ASA in acute KD
🗣Refractory cases may require steroids or additional immunosuppression
🫀Get echos on all patients to assess for coronary aneurysms
Catherine Sims, MD @DrCassySims ( View Tweet )
3 years 8 months ago
Tawanese claims analysis of 10,857 RA pts shows lower CVA rates when taking Celebrex (5.95% vs 9.72% not taking) or Etoricoxib (2.69% vs 8.51% not taking). Both Celebrex/Etoricoxib significantly reduced stroke risk p < 0.001 https://t.co/6idrH9g0LJ https://t.co/d80bEtsP7k
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 9 months ago
FDA has approves RINVOQ (upadacitinib) for the treatment of Active Non-Radiographic Axial Spondyloarthritis https://t.co/DMuQFjFdrf https://t.co/zLsniZ2zOg
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 9 months ago
Health Canada has approved EVUSHELD to treat COVID-19 in immunocompromised patients (it was previously approved to prevent COVID) https://t.co/ePgd4DjTka https://t.co/whgSM3ce7Q
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 9 months ago
Follow us for real time coverage #ACR2022 https://t.co/5CBdiKWdKM
Dr. John Cush @RheumNow ( View Tweet )
3 years 9 months ago
“If you torture the data long enough it will confess” -Ronald Coase (economist) https://t.co/ZGivhUWLZW
Dr. John Cush @RheumNow ( View Tweet )
3 years 9 months ago
How do Pts check Temps? Paired oral & temporal temps in 2031 Blacks & 2344 Whites: / whites showed no diff (36.97 vs 36.95°C), but signif diff in blacks (36.98 vs 37.05). Fever seen in 10.2-10.8% Whites, but 10.1% (temporal), 13.2% (oral) in Blacks https://t.co/D4XowfsYXD https://t.co/LmvEnAVGbr
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 9 months ago
Pregnancy Outcomes with Belimumab
A study of SLE pregnancies exposed to belimumab (BEL) shows and expected rate of pregnancy loss but a variable rate of birth defects.
https://t.co/cXm58iSmVc https://t.co/Hdg6Qg1uHE
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 9 months ago
